GH

Guardant Health, Inc. · Healthcare · Market cap $21.9B

Insiders sold $30.7M net in the last 90 days ·10 sellers, 0 buyers· latest Form 4 filed Oct 19, 2026

Insider Buying

$78K

reported purchases (SEC code P)

Insider Selling

$168.7M

reported sales (SEC code S)

Unique Insiders

15

in the rolling window

Latest filing

Oct 22, 2026

Tariq Musa

Guardant Health, Inc. (GH) has 159 SEC Form 4 filings (459 transaction rows) in the rolling window, disclosed by 15 distinct insiders. Most recent filing: Oct 22, 2026.

Inside the rolling window, 15 insiders at Guardant Health, Inc. reported 1 open-market purchase totaling $78K and 57 open-market sales totaling $168.7M. The most active filer is Director Tariq Musa with 11 filings. Insiders have net sold $122.5M over the trailing 6 months. The most recent open-market filing is a sale of 116 shares by Director Tariq Musa, dated Oct 16, 2026, worth $19K.

  • Industry:Medical - Diagnostics & Research
  • CEO:Helmy Eltoukhy
  • Employees:2,498
  • HQ:Palo Alto, CA, US
  • IPO:2018-10-04
Source
Sale$19KOct 19SEC ↗
Sale$11KOct 15SEC ↗
Sale$20KSep 17SEC ↗
Krognes Steve E.First in 3 months
Sale$1.2MSep 17SEC ↗
Azar Alex M IIFirst filing
Sale$145KSep 17SEC ↗
Chudova DaryaFirst in 9 months
Sale$1.4MSep 17SEC ↗
Sale$632KSep 14SEC ↗
Sale$6.3MAug 24SEC ↗
Sale$18KAug 18SEC ↗
Monroe Terilyn J.First in 4 months
Sale$7.6MAug 13SEC ↗
Sale$10.8MAug 11SEC ↗
Sale$279KAug 6SEC ↗
Sale$2.3MAug 5SEC ↗
Sale$19KJul 16SEC ↗
Sale$731KJun 30SEC ↗
Purchase$78KJun 30SEC ↗
Sale$79KJun 30SEC ↗
Sale$17.6MJun 30SEC ↗
Sale$21.7MJun 30SEC ↗
POTTER MYRTLE SFirst filing
Sale$204KJun 23SEC ↗
Sale$256KJun 23SEC ↗
Sale$15KJun 16SEC ↗
Sale$445KJun 15SEC ↗
Eltoukhy HelmyFirst in 6 months
Sale$12.6MJun 8SEC ↗
Sale$257KJun 8SEC ↗
Showing 1–25 of 58
1 / 3

Earnings: last 7 quarters

EstimatedActual

Congress trading GH 12 all-time

  • DSen. Sheldon WhitehousePurchase$1,001 - $15,0002025-11-21
  • DSen. Sheldon WhitehousePurchase$1,001 - $15,0002025-11-21
  • DRep. Donald Sternoff BeyerOther$1,001 - $15,0002022-02-28
  • DRep. Donald Sternoff BeyerOther$1,001 - $15,0002022-01-13
  • DRep. Donald Sternoff BeyerOther$1,001 - $15,0002021-12-22
  • DRep. Donald Sternoff BeyerPurchase$1,001 - $15,0002020-11-02

STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.

Frequently asked questions

How many SEC Form 4 insider filings does GH have?

Guardant Health, Inc. (GH) has 159 SEC Form 4 filings (459 transaction rows) in the rolling 365-day window, disclosed by 15 distinct insiders. Most recent filing: Oct 22, 2026.

When was the most recent SEC Form 4 filing for GH?

The most recent Form 4 filing for GH on Tracefour is dated Oct 22, 2026.

Who is the most active insider at GH?

The most active SEC Form 4 filer at GH in the rolling window is Director Tariq Musa, with 11 filings.

What is the net insider flow at GH over the last 6 months?

Over the trailing 180 days, insiders at GH have net sold $122.5M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at GH in the current window?

Inside the rolling window, insiders at GH bought $78K and sold $168.7M based on SEC Form 4 filings.

Can I get alerts for GH insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Guardant Health, Inc. (GH). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Guardant Health, Inc. is in the Healthcare sector.